Venous Thromboembolism Risk Following Total Joint Arthroplasty in Rheumatoid Arthritis Patients Treated with Janus Kinase Inhibitors Versus Tumor Necrosis Factor Inhibitors: A Propensity Score-Matched Cohort Study
Among RA patients undergoing primary TJA, JAK inhibitor use was not associated with a statistically significant increase in postoperative VTE compared with TNF inhibitor use, although VTE events occurred numerically more often in the JAK inhibitor cohort.